NDC product
Guaifenesin and Dextromethorphan hydrobromide
NDC 83720-501 · Oncor Pharmaceuticals
Key facts
| Product NDC | 83720-501 |
|---|---|
| Proprietary name | Guaifenesin and Dextromethorphan hydrobromide |
| Labeler | Oncor Pharmaceuticals |
| Marketing category | OTC MONOGRAPH DRUG |
| Application number | M012 |
| Marketing start | Feb 1, 2025 |
| Marketing end | Feb 1, 2025 |
| Listing certified through | Feb 1, 2025 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: